ID   STK40_HUMAN             Reviewed;         435 AA.
AC   Q8N2I9; D3DPS8; Q5VTK8; Q5VTK9; Q6ZMN1; Q8N2J8; Q8N3I6; Q96HN6; Q96I44;
AC   Q9BSA3; Q9H7H6;
DT   17-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   12-OCT-2022, entry version 162.
DE   RecName: Full=Serine/threonine-protein kinase 40;
DE            EC=2.7.11.1;
DE   AltName: Full=SINK-homologous serine/threonine-protein kinase;
DE   AltName: Full=Sugen kinase 495;
DE            Short=SgK495;
GN   Name=STK40; Synonyms=SGK495, SHIK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   Shan Y.X., Wu H., Yu L.;
RT   "Cloning and characterization of a novel Ser/Thr-like kinase.";
RL   Submitted (DEC-2002) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3), AND VARIANT
RP   THR-395.
RC   TISSUE=Ovary, Spleen, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Melanoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4), AND VARIANT
RP   THR-395.
RC   TISSUE=Kidney, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   IDENTIFICATION.
RX   PubMed=12471243; DOI=10.1126/science.1075762;
RA   Manning G., Whyte D.B., Martinez R., Hunter T., Sudarsanam S.;
RT   "The protein kinase complement of the human genome.";
RL   Science 298:1912-1934(2002).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=13679039; DOI=10.1016/j.bbrc.2003.08.069;
RA   Huang J., Teng L., Liu T., Li L., Chen D., Li F., Xu L.-G., Zhai Z.,
RA   Shu H.-B.;
RT   "Identification of a novel serine/threonine kinase that inhibits TNF-
RT   induced NF-kappaB activation and p53-induced transcription.";
RL   Biochem. Biophys. Res. Commun. 309:774-778(2003).
RN   [9]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-10; THR-133; GLN-211 AND THR-395.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: May be a negative regulator of NF-kappa-B and p53-mediated
CC       gene transcription. {ECO:0000269|PubMed:13679039}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- INTERACTION:
CC       Q8N2I9; Q9GZT3: SLIRP; NbExp=3; IntAct=EBI-716112, EBI-1050793;
CC       Q8N2I9; Q96RU8: TRIB1; NbExp=4; IntAct=EBI-716112, EBI-492555;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:13679039}. Cytoplasm
CC       {ECO:0000269|PubMed:13679039}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q8N2I9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8N2I9-2; Sequence=VSP_020896, VSP_020898;
CC       Name=3;
CC         IsoId=Q8N2I9-3; Sequence=VSP_020899, VSP_020900;
CC       Name=4;
CC         IsoId=Q8N2I9-4; Sequence=VSP_020897;
CC   -!- TISSUE SPECIFICITY: Strongly expressed in heart, brain, placenta, lung,
CC       skeletal muscle, kidney, spleen, thymus, prostate, liver, pancreas,
CC       testis, ovary, small intestine, colon and peripheral blood leukocytes.
CC       {ECO:0000269|PubMed:13679039}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH08344.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAB15794.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAC11361.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY198395; AAP20040.1; -; mRNA.
DR   EMBL; AK024504; BAB15794.1; ALT_INIT; mRNA.
DR   EMBL; AK075029; BAC11361.1; ALT_INIT; mRNA.
DR   EMBL; AK075048; BAC11371.1; -; mRNA.
DR   EMBL; AK131560; BAD18694.1; -; mRNA.
DR   EMBL; AL834137; CAD38852.1; -; mRNA.
DR   EMBL; AL591845; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471059; EAX07371.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07373.1; -; Genomic_DNA.
DR   EMBL; BC005169; AAH05169.3; -; mRNA.
DR   EMBL; BC007835; AAH07835.2; -; mRNA.
DR   EMBL; BC008344; AAH08344.1; ALT_INIT; mRNA.
DR   CCDS; CCDS407.1; -. [Q8N2I9-1]
DR   CCDS; CCDS60089.1; -. [Q8N2I9-4]
DR   RefSeq; NP_001269475.1; NM_001282546.1. [Q8N2I9-4]
DR   RefSeq; NP_001269476.1; NM_001282547.1. [Q8N2I9-1]
DR   RefSeq; NP_114406.1; NM_032017.2. [Q8N2I9-1]
DR   PDB; 5L2Q; X-ray; 2.53 A; A/B/C/D=22-339.
DR   PDBsum; 5L2Q; -.
DR   AlphaFoldDB; Q8N2I9; -.
DR   SMR; Q8N2I9; -.
DR   BioGRID; 123816; 55.
DR   IntAct; Q8N2I9; 25.
DR   MINT; Q8N2I9; -.
DR   STRING; 9606.ENSP00000362222; -.
DR   iPTMnet; Q8N2I9; -.
DR   PhosphoSitePlus; Q8N2I9; -.
DR   BioMuta; STK40; -.
DR   DMDM; 116256080; -.
DR   jPOST; Q8N2I9; -.
DR   MassIVE; Q8N2I9; -.
DR   MaxQB; Q8N2I9; -.
DR   PaxDb; Q8N2I9; -.
DR   PeptideAtlas; Q8N2I9; -.
DR   PRIDE; Q8N2I9; -.
DR   ProteomicsDB; 71707; -. [Q8N2I9-1]
DR   ProteomicsDB; 71709; -. [Q8N2I9-3]
DR   ProteomicsDB; 71710; -. [Q8N2I9-4]
DR   Antibodypedia; 2156; 167 antibodies from 28 providers.
DR   DNASU; 83931; -.
DR   Ensembl; ENST00000359297.6; ENSP00000352245.2; ENSG00000196182.11. [Q8N2I9-3]
DR   Ensembl; ENST00000373129.7; ENSP00000362221.3; ENSG00000196182.11. [Q8N2I9-1]
DR   Ensembl; ENST00000373130.7; ENSP00000362222.3; ENSG00000196182.11. [Q8N2I9-4]
DR   Ensembl; ENST00000373132.4; ENSP00000362224.4; ENSG00000196182.11. [Q8N2I9-1]
DR   GeneID; 83931; -.
DR   KEGG; hsa:83931; -.
DR   MANE-Select; ENST00000373132.4; ENSP00000362224.4; NM_001282547.2; NP_001269476.1.
DR   UCSC; uc001cak.3; human. [Q8N2I9-1]
DR   CTD; 83931; -.
DR   DisGeNET; 83931; -.
DR   GeneCards; STK40; -.
DR   HGNC; HGNC:21373; STK40.
DR   HPA; ENSG00000196182; Low tissue specificity.
DR   MIM; 609437; gene.
DR   neXtProt; NX_Q8N2I9; -.
DR   OpenTargets; ENSG00000196182; -.
DR   PharmGKB; PA142670860; -.
DR   VEuPathDB; HostDB:ENSG00000196182; -.
DR   eggNOG; KOG0583; Eukaryota.
DR   GeneTree; ENSGT00950000182986; -.
DR   HOGENOM; CLU_035107_0_0_1; -.
DR   InParanoid; Q8N2I9; -.
DR   OMA; GRDAQPM; -.
DR   OrthoDB; 1362510at2759; -.
DR   PhylomeDB; Q8N2I9; -.
DR   TreeFam; TF329785; -.
DR   PathwayCommons; Q8N2I9; -.
DR   SignaLink; Q8N2I9; -.
DR   SIGNOR; Q8N2I9; -.
DR   BioGRID-ORCS; 83931; 44 hits in 1120 CRISPR screens.
DR   ChiTaRS; STK40; human.
DR   GeneWiki; STK40; -.
DR   GenomeRNAi; 83931; -.
DR   Pharos; Q8N2I9; Tbio.
DR   PRO; PR:Q8N2I9; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q8N2I9; protein.
DR   Bgee; ENSG00000196182; Expressed in gastrocnemius and 151 other tissues.
DR   Genevisible; Q8N2I9; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0005977; P:glycogen metabolic process; IEA:Ensembl.
DR   GO; GO:0048286; P:lung alveolus development; IEA:Ensembl.
DR   GO; GO:0060425; P:lung morphogenesis; IEA:Ensembl.
DR   GO; GO:0035264; P:multicellular organism growth; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0006468; P:protein phosphorylation; IEA:InterPro.
DR   GO; GO:0010468; P:regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0043408; P:regulation of MAPK cascade; IEA:Ensembl.
DR   GO; GO:0003016; P:respiratory system process; IEA:Ensembl.
DR   CDD; cd13974; STKc_SHIK; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR024236; Ser/Thr_kinase_40.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR024104; Tribbles/Ser_Thr_kinase_40.
DR   PANTHER; PTHR22961; PTHR22961; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cytoplasm; Kinase;
KW   Nucleotide-binding; Nucleus; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..435
FT                   /note="Serine/threonine-protein kinase 40"
FT                   /id="PRO_0000252261"
FT   DOMAIN          35..331
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..25
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        196
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         41..49
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         66
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   VAR_SEQ         1..262
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_020896"
FT   VAR_SEQ         37
FT                   /note="L -> LALCAV (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_020897"
FT   VAR_SEQ         263..295
FT                   /note="VLFTMLYGQFPFYDSIPQELFRKIKAAEYTIPE -> MGLRQGNGTVSLGIL
FT                   ATDPAPPTEPSSPTPCLR (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_020898"
FT   VAR_SEQ         364..417
FT                   /note="AKVTEECSQYEFENYMRQQLLLAEEKSSIHDARSWVPKRQFGSAPPVRRLGH
FT                   DA -> VSWGGQMGHYPAPRDRLLGAGRARAEVAATRRPQSFLGLLPQPWGGKGRLQSS
FT                   A (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_020899"
FT   VAR_SEQ         418..435
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_020900"
FT   VARIANT         10
FT                   /note="A -> V (in dbSNP:rs56314546)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041200"
FT   VARIANT         133
FT                   /note="M -> T (in a colorectal adenocarcinoma sample;
FT                   somatic mutation; dbSNP:rs755089893)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041201"
FT   VARIANT         211
FT                   /note="R -> Q (in a colorectal adenocarcinoma sample;
FT                   somatic mutation; dbSNP:rs539738963)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041202"
FT   VARIANT         395
FT                   /note="A -> T (in dbSNP:rs3795498)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041203"
FT   CONFLICT        191
FT                   /note="Missing (in Ref. 2; BAC11371)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        363
FT                   /note="E -> Q (in Ref. 6; AAH05169)"
FT                   /evidence="ECO:0000305"
FT   STRAND          49..52
FT                   /evidence="ECO:0007829|PDB:5L2Q"
FT   TURN            57..59
FT                   /evidence="ECO:0007829|PDB:5L2Q"
FT   STRAND          64..69
FT                   /evidence="ECO:0007829|PDB:5L2Q"
FT   HELIX           81..97
FT                   /evidence="ECO:0007829|PDB:5L2Q"
FT   HELIX           98..100
FT                   /evidence="ECO:0007829|PDB:5L2Q"
FT   STRAND          109..115
FT                   /evidence="ECO:0007829|PDB:5L2Q"
FT   STRAND          124..126
FT                   /evidence="ECO:0007829|PDB:5L2Q"
FT   STRAND          128..130
FT                   /evidence="ECO:0007829|PDB:5L2Q"
FT   STRAND          136..141
FT                   /evidence="ECO:0007829|PDB:5L2Q"
FT   HELIX           152..155
FT                   /evidence="ECO:0007829|PDB:5L2Q"
FT   HELIX           159..164
FT                   /evidence="ECO:0007829|PDB:5L2Q"
FT   STRAND          165..168
FT                   /evidence="ECO:0007829|PDB:5L2Q"
FT   HELIX           171..190
FT                   /evidence="ECO:0007829|PDB:5L2Q"
FT   HELIX           200..202
FT                   /evidence="ECO:0007829|PDB:5L2Q"
FT   STRAND          203..205
FT                   /evidence="ECO:0007829|PDB:5L2Q"
FT   TURN            207..209
FT                   /evidence="ECO:0007829|PDB:5L2Q"
FT   STRAND          212..214
FT                   /evidence="ECO:0007829|PDB:5L2Q"
FT   TURN            237..239
FT                   /evidence="ECO:0007829|PDB:5L2Q"
FT   HELIX           242..245
FT                   /evidence="ECO:0007829|PDB:5L2Q"
FT   HELIX           252..269
FT                   /evidence="ECO:0007829|PDB:5L2Q"
FT   HELIX           279..288
FT                   /evidence="ECO:0007829|PDB:5L2Q"
FT   HELIX           301..310
FT                   /evidence="ECO:0007829|PDB:5L2Q"
FT   STRAND          315..318
FT                   /evidence="ECO:0007829|PDB:5L2Q"
FT   HELIX           321..333
FT                   /evidence="ECO:0007829|PDB:5L2Q"
SQ   SEQUENCE   435 AA;  49001 MW;  EBA7A19963582BCC CRC64;
     MKRRASDRGA GETSARAKAL GSGISGNNAK RAGPFILGPR LGNSPVPSIV QCLARKDGTD
     DFYQLKILTL EERGDQGIES QEERQGKMLL HTEYSLLSLL HTQDGVVHHH GLFQDRTCEI
     VEDTESSRMV KKMKKRICLV LDCLCAHDFS DKTADLINLQ HYVIKEKRLS ERETVVIFYD
     VVRVVEALHQ KNIVHRDLKL GNMVLNKRTH RITITNFCLG KHLVSEGDLL KDQRGSPAYI
     SPDVLSGRPY RGKPSDMWAL GVVLFTMLYG QFPFYDSIPQ ELFRKIKAAE YTIPEDGRVS
     ENTVCLIRKL LVLDPQQRLA AADVLEALSA IIASWQSLSS LSGPLQVVPD IDDQMSNADS
     SQEAKVTEEC SQYEFENYMR QQLLLAEEKS SIHDARSWVP KRQFGSAPPV RRLGHDAQPM
     TSLDTAILAQ RYLRK
//
